CYMERUS Trademark

Trademark Overview

On Thursday, January 9, 2014, a trademark application was filed for CYMERUS with the United States Patent and Trademark Office. The USPTO has given the CYMERUS trademark a serial number of 79150051. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, February 27, 2025. This trademark is owned by Cynata Therapeutics Ltd. The CYMERUS trademark is filed in the Pharmaceutical Products category with the following description:

Biological products for medical use, namely, cells for medical use; biological tissue cultures for medical purposes; stem cells for medical purposes; therapeutic biological products for therapeutic purposes, namely, cells for medical use
cymerus

General Information

Serial Number79150051
Word MarkCYMERUS
Filing DateThursday, January 9, 2014
Status706 - SECTION 71 ACCEPTED
Status DateThursday, February 27, 2025
Registration Number4686522
Registration DateTuesday, February 17, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Goods and ServicesBiological products for medical use, namely, cells for medical use; biological tissue cultures for medical purposes; stem cells for medical purposes; therapeutic biological products for therapeutic purposes, namely, cells for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 4, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCynata Therapeutics Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressARMADALE VIC 3143
AU
Party NameCynata Therapeutics Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameCynata Therapeutics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Thursday, July 31, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, August 13, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 13, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 1, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, August 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 4, 2014ASSIGNED TO EXAMINER
Friday, August 8, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, August 12, 2014NON-FINAL ACTION WRITTEN
Wednesday, August 13, 2014REFUSAL PROCESSED BY MPU
Friday, August 29, 2014REFUSAL PROCESSED BY IB
Wednesday, October 1, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, October 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 28, 2014ASSIGNED TO LIE
Wednesday, October 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 12, 2014NOTICE OF PUBLICATION
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2015REGISTERED-PRINCIPAL REGISTER
Sunday, May 17, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 30, 2015FINAL DISPOSITION PROCESSED
Tuesday, June 30, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 17, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Saturday, January 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, June 10, 2021TEAS SECTION 71 RECEIVED
Monday, November 29, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 2, 2014EXAMINERS AMENDMENT MAILED
Thursday, February 15, 2024INTERNATIONAL REGISTRATION RENEWED
Saturday, February 17, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, September 9, 2024TEAS SECTION 71 RECEIVED
Monday, January 10, 2022REGISTERED-SEC.71 ACCEPTED
Monday, January 10, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, February 23, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 27, 2025REGISTERED-SEC.71 ACCEPTED
Thursday, February 27, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

cymerus medical purposes biological cells products namely therapeutic stem cultures tissue